Pharma Journalist 9038 posts 0 comments

HiFiBiO Therapeutics, a multinational biotherapeutics company with unique expertise in immune modulation and single-cell science, today announced the successful completion of the first…
Read More...

Knight Therapeutics Inc. a leading pan-American (ex-US) specialty pharmaceutical company, announced the signing of a new exclusive distribution agreement with Gilead Sciences, Inc. for…
Read More...

Bayer AG announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing…
Read More...

ANA Therapeutics announced that it has begun a multicenter, Phase 2/3 clinical trial to evaluate the safety and efficacy of its proprietary, oral niclosamide (ANA001) formulation for…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators in the US, UK, Brazil, South Africa and Japan confirming that it…
Read More...

Gilead Sciences, Inc. announced the completion of the previously announced transaction to acquire Immunomedics, Inc. for approximately $21 billion in the aggregate. “We are very…
Read More...

We are only two weeks away from the much-anticipated 2nd Digital Exosome Based Therapeutic Development Summit (November 11-12). Bringing together industry leaders and newcomers in the…
Read More...

Avalon GloboCare Corp. and Adial Pharmaceuticals, Inc. announced formation of a strategic collaboration for global distribution of the Assure/Fastep COVID-19 IgG/IgM Rapid Test device…
Read More...

Catalent and BrainStorm Cell Therapeutics Inc announced an agreement for the manufacture of NurOwn, BrainStorm’s autologous cellular therapy being investigated for the treatment of…
Read More...